[ Price : $8.95]
An FDA co-designed study suggests that drug developers could conduct robust cardiac safety characterizations several years earlier...[ Price : $8.95]
FDA grants the first-ever Clinical Laboratory Improvement Amendments (CLIA) waiver for Veda Labs (Alencon, France) rapid screening...[ Price : $8.95]
ChemoCentryx says a 52-week Phase 2 clinical trial involving its orally administered C-C chemokine receptor 2 antagonist CCX140 in...[ Price : $8.95]
FDA grants approval to MP Biomedicals for its MP Diagnostics Human T-Cell Lymphotropic Virus Blot 2.4, a Western Blot for HTLV con...[ Price : $8.95]
New York Attorney General Eric T. Schneiderman wins a preliminary injunction against Actavis that requires the company to continue...[ Price : $8.95]
FDA approves a Sanofi Pasteur supplemental BLA for Fluzone Intradermal Quadrivalent vaccine.[ Price : $8.95]
FDA approves an Eli Lilly supplemental NDA to expand the approved use of Cyramza (ramucirumab) to treat patients with metastatic n...[ Price : $8.95]
Senators Orrin Hatch (R-UT) and Michael Bennet (D-CO) have introduced the Dormant Therapies Act, a bill that will establish a new ...